Profilo
Jean Combalbert is the founder of Epics Therapeutics SA, serving as Director since 2018.
Current job includes Chairman at Syndesi Therapeutics SA. Former jobs include Chairman & Chief Executive Officer at Entomed SA from 2003 to 2009, Chief Executive Officer & Director at Ogeda SA, Non-Executive Chairman at Bioxodes SA, Director at Pharnext SA from 2020 to 2021, and Principal at Sanofi.
Education includes a doctorate from the University of Marseille.
Posizioni attive di Jean Combalbert
| Società | Posizione | Inizio |
|---|---|---|
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Fondatore | 20/02/2018 |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Presidente | - |
Precedenti posizioni note di Jean Combalbert
| Società | Posizione | Fine |
|---|---|---|
| PHARNEXT SCA | Direttore/Membro del Consiglio | 15/07/2021 |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Presidente | 03/02/2009 |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Presidente | - |
| SANOFI | Corporate Officer/Principal | - |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Amministratore Delegato | - |
Formazione di Jean Combalbert
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Entomed SA
Entomed SA Pharmaceuticals: MajorHealth Technology Discovers and develops anti-infective drugs derived from insects | Health Technology |
Ogeda SA
Ogeda SA Pharmaceuticals: MajorHealth Technology Discovers and develops small molecule drugs | Health Technology |
University of Marseille
University of Marseille Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharnext SA
Pharnext SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies for patients to treat neurodegenerative diseases | Health Technology |
Bioxodes SA
Bioxodes SA BiotechnologyHealth Technology Operates as a clinical-stage biotech company that develops therapeutics targeting thrombo-inflammation | Health Technology |
Syndesi Therapeutics SA
Syndesi Therapeutics SA BiotechnologyHealth Technology Develops treatments for CNS disorders | Health Technology |
Epics Therapeutics SA
Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
















